Hy-Tech may outshine Skyways, Symbiotec on listing day, GMP signals

Hy-Tech Engineers IPO GMP is 79 per cent, while Skyways Air and Symbiotec Pharmalab are expected to list at over 20 per cent premium.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.